SANUWAVE will host a 30-minute live conference call and webcast November 15, 2022 at 9:00 AM to provide business update
Eden Prairie, MN - (NewMediaWire) - November 14, 2022 - SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, will host a 30-minute live conference call on Tuesday, November 15, 2022, at 9:00AM (EDT) to discuss recent business activity, provide an update on SEC filings, and detail strategic initiatives.
A webcast with an accompanying PowerPoint presentation will be accessible here.
Telephone access to the call will also be available by dialing the following numbers:
Conference ID: 13734492
A replay will be made available through November 29, 2022:
Replay Passcode: 13734492
If you are unable to access the webcast you can follow along with the presentation by visiting the Investors page of SANUWAVE’s website – accessible here.
The company will also share this link on the day of the presentation via LinkedIn.
SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
SANUWAVE’s end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future business development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with the regulatory approval and marketing of the Company’s product candidates and products, unproven pre-clinical and clinical development activities, regulatory oversight, the Company’s ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Senior Director, Marketing & Program Management
INVESTOR RELATIONS CONTACT: